E. Scheibel

1.7k total citations
43 papers, 1.3k citations indexed

About

E. Scheibel is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, E. Scheibel has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in E. Scheibel's work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). E. Scheibel is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). E. Scheibel collaborates with scholars based in Denmark, Sweden and United States. E. Scheibel's co-authors include G C White, Marilyn J. Manco‐Johnson, Ralph A. Gruppo, Amy D. Shapiro, S Courter, Gordon Em, Lee M, Gomperts Ed, J. Ingerslev and H Hertz and has published in prestigious journals such as Blood, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

E. Scheibel

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Scheibel Denmark 15 896 211 191 162 142 43 1.3k
B. L. Evatt United States 15 1.2k 1.4× 309 1.5× 114 0.6× 158 1.0× 93 0.7× 24 1.8k
Hideji Hanabusa Japan 18 957 1.1× 257 1.2× 180 0.9× 252 1.6× 138 1.0× 51 1.4k
J.A. Gastaut France 16 514 0.6× 127 0.6× 149 0.8× 251 1.5× 122 0.9× 38 1.1k
H.‐H. Brackmann Germany 24 1.3k 1.4× 318 1.5× 336 1.8× 239 1.5× 186 1.3× 65 2.1k
JL Fahey United States 13 397 0.4× 147 0.7× 62 0.3× 109 0.7× 128 0.9× 17 752
MV Ragni United States 15 401 0.4× 203 1.0× 71 0.4× 171 1.1× 139 1.0× 28 808
Y. Brossard France 21 769 0.9× 211 1.0× 100 0.5× 430 2.7× 148 1.0× 82 1.3k
Dawn Jones United States 17 758 0.8× 109 0.5× 148 0.8× 97 0.6× 171 1.2× 28 1.4k
Rosemary J. D. Spooner United Kingdom 13 924 1.0× 232 1.1× 174 0.9× 308 1.9× 171 1.2× 15 1.6k
Hideki Nakayama Japan 18 501 0.6× 76 0.4× 175 0.9× 87 0.5× 50 0.4× 68 1.1k

Countries citing papers authored by E. Scheibel

Since Specialization
Citations

This map shows the geographic impact of E. Scheibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Scheibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Scheibel more than expected).

Fields of papers citing papers by E. Scheibel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Scheibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Scheibel. The network helps show where E. Scheibel may publish in the future.

Co-authorship network of co-authors of E. Scheibel

This figure shows the co-authorship network connecting the top 25 collaborators of E. Scheibel. A scholar is included among the top collaborators of E. Scheibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Scheibel. E. Scheibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iversen, Astrid K. N., C Christiansen, Jørn Attermann, et al.. (2003). Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus. The Journal of Infectious Diseases. 187(2). 215–225. 10 indexed citations
2.
3.
Ljung, Rolf, Marijke van den Berg, Hérvè Chambost, et al.. (2000). Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia. 6(6). 619–624. 58 indexed citations
4.
Scheibel, E.. (1999). von Willebrand disease in Denmark: demography and treatment. Haemophilia. 5(s2). 71–71. 5 indexed citations
5.
Scheibel, E., et al.. (1998). Approaches towards successful home treatment in patients with inhibitors. European Journal Of Haematology. 61(S63). 11–14. 22 indexed citations
6.
Jensen, Anni Ravnsbæk, et al.. (1997). Variability of the factor VIII response to DDAVP in a large kindred with mild haemophilia A. Haemophilia. 3(4). 259–264. 3 indexed citations
7.
Ingerslev, J., D A Gastineau, Gerald Gilchrist, et al.. (1996). Major Surgery in Haemophilic Patients with Inhibitors Using Recombinant Factor VIla. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 118–123. 109 indexed citations
8.
Mariani, Giuliano, E. Scheibel, Kasper Ck, et al.. (1994). Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.. PubMed. 31(2 Suppl 4). 62–4. 38 indexed citations
9.
Bray, Gordon L., Edward D. Gomperts, Ralph A. Gruppo, et al.. (1994). A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A. Blood. 83(9). 2428–2435. 126 indexed citations
10.
Donnér, Mikael, H. Lenk, E. Scheibel, et al.. (1992). Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden. British Journal of Haematology. 82(1). 58–65. 18 indexed citations
11.
Cooper, D.N., et al.. (1992). Prenatal exclusion of haemophilia a and carrier testing by direct detection of a disease lesion. Prenatal Diagnosis. 12(11). 861–866. 1 indexed citations
12.
Arendrup, Maiken Cavling, Carsten M. Nielsen, John‐Erik Stig Hansen, et al.. (1992). Neutralizing Antibodies against two HIV-1 Strains in Consecutively Collected Serum Samples: Cross Neutralization and Association to HIV-1 Related Disease. Scandinavian Journal of Infectious Diseases. 24(1). 21–28. 10 indexed citations
13.
Pedersen, C., Bjarne Ørskov Lindhardt, B L Jensen, et al.. (1989). Clinical course of primary HIV infection: consequences for subsequent course of infection.. BMJ. 299(6692). 154–157. 125 indexed citations
14.
Brown, Peter de Nully, H Hertz, Jørgen H. Olsen, et al.. (1989). Incidence of Childhood Cancer in Denmark 1943–1984. International Journal of Epidemiology. 18(3). 546–555. 73 indexed citations
15.
Lindhardt, Bjarne Ørskov, Edgar Lauritzen, Birgit Kvinesdal, et al.. (1989). Serological Markers of Primary HIV Infection. Scandinavian Journal of Infectious Diseases. 21(5). 491–496. 3 indexed citations
16.
Taaning, Ellen, E. Scheibel, Birgitte Schantz Laursen, & J. Ingerslev. (1988). Pattern of Immunoglobulin Classes and IgG Subclasses of Platelet‐Associated Immunoglobulin in HIV‐Seropositive Haemophiliacs. Vox Sanguinis. 54(4). 205–209. 5 indexed citations
17.
Stender, Steen, et al.. (1987). An effect of predilution on VIII: C determination by the one-stage assay. Thrombosis Research. 48(2). 195–203. 8 indexed citations
18.
Olsen, Jørgen H. & E. Scheibel. (1984). [Cancer in childhood in Denmark 1943-1980. Cancer statistics No. 11].. PubMed. 146(42). 3228–30. 3 indexed citations
19.
Friis-Hansen, B, et al.. (1979). The influence of apnea and physical activity on arterial blood pressure and transcutaneous oxygen tension in the newborn.. PubMed. 15(4). 461–8. 1 indexed citations
20.
Verder, Henrik, Peter A. Krasilnikoff, & E. Scheibel. (1975). ANAL TONOMETRY IN THE NEONATAL PERIOD IN MATURE AND PREMATURE CHILDREN. Acta Paediatrica. 64(4). 592–596. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026